Application of Nanotechnology in Therapeutic Cancer Vaccines
Cancer vaccines stimulate the immune system within the body by introducing tumor antigens in various forms, such as tumor cells, tumor‐related proteins or peptides, and genes expressing tumor antigens, into the body. This activation of the immune response aims to prevent or treat tumors. Preventive cancer vaccines are primarily targeted at cancers caused by viral infections, and most cancer vaccines are currently designed as therapeutic vaccines for cancer treatment. In this review, the development of cancer vaccines, the mechanism of action, the types of antigens, and the progress of nanotechnology in therapeutic cancer vaccines are summarized. The development and application of cancer vaccines incorporating tumor‐specific antigens and nanomaterials are anticipated.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Application of Nanotechnology in Therapeutic Cancer Vaccines ; day:05 ; month:05 ; year:2023 ; extent:12
Advanced nanoBiomed research ; (05.05.2023) (gesamt 12)
- Urheber
-
Guo, Jianmei
Tang, Lin
Li, Kelin
Ma, Qingxin
Luo, Shuda
Cheng, Ruoyu
Liu, Chaoyong
- DOI
-
10.1002/anbr.202200122
- URN
-
urn:nbn:de:101:1-2023050615041058460353
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Guo, Jianmei
- Tang, Lin
- Li, Kelin
- Ma, Qingxin
- Luo, Shuda
- Cheng, Ruoyu
- Liu, Chaoyong
Ähnliche Objekte (12)
Nanotechnology‐Assisted Immunoengineering for Cancer Vaccines
Nanotechnology-Based Nucleic Acid Vaccines for Treatment of Ovarian Cancer
Application of nanotechnology to cancer radiotherapy
Oncolytic viruses as therapeutic cancer vaccines
Therapeutic cancer vaccines: advancements, challenges, and prospects
Human Cytomegalovirus (HCMV)-based Therapeutic Cancer Vaccines
Turning the corner on therapeutic cancer vaccines
Therapeutic dendritic cell cancer vaccines in hematologic malignancies
Nanotechnology Promotes Genetic and Functional Modifications of Therapeutic T Cells Against Cancer
Bacterial nanotechnology as a paradigm in targeted cancer therapeutic delivery and immunotherapy
Adjuvants for cancer mRNA vaccines in the era of nanotechnology: strategies, applications, and future directions
Viral vector-based therapeutic HPV vaccines
Nanotechnology‐Assisted Immunoengineering for Cancer Vaccines
Nanotechnology-Based Nucleic Acid Vaccines for Treatment of Ovarian Cancer
Application of nanotechnology to cancer radiotherapy
Oncolytic viruses as therapeutic cancer vaccines
Therapeutic cancer vaccines: advancements, challenges, and prospects
Human Cytomegalovirus (HCMV)-based Therapeutic Cancer Vaccines
Turning the corner on therapeutic cancer vaccines
Therapeutic dendritic cell cancer vaccines in hematologic malignancies
Nanotechnology Promotes Genetic and Functional Modifications of Therapeutic T Cells Against Cancer
Bacterial nanotechnology as a paradigm in targeted cancer therapeutic delivery and immunotherapy
Adjuvants for cancer mRNA vaccines in the era of nanotechnology: strategies, applications, and future directions
Viral vector-based therapeutic HPV vaccines
Nanotechnology‐Assisted Immunoengineering for Cancer Vaccines
Nanotechnology-Based Nucleic Acid Vaccines for Treatment of Ovarian Cancer
Application of nanotechnology to cancer radiotherapy
Oncolytic viruses as therapeutic cancer vaccines
Therapeutic cancer vaccines: advancements, challenges, and prospects
Human Cytomegalovirus (HCMV)-based Therapeutic Cancer Vaccines
Turning the corner on therapeutic cancer vaccines
Therapeutic dendritic cell cancer vaccines in hematologic malignancies
Nanotechnology Promotes Genetic and Functional Modifications of Therapeutic T Cells Against Cancer
Bacterial nanotechnology as a paradigm in targeted cancer therapeutic delivery and immunotherapy
Adjuvants for cancer mRNA vaccines in the era of nanotechnology: strategies, applications, and future directions